Moderate

Chronic (domiciliary) non-invasive ventilation

home NIV · Respiratory
Physician-written · Verified by three sets of doctors · Reviewed November 2026

Bedside summary

Long-term home non-invasive ventilation supports patients with chronic hypercapnic respiratory failure from COPD, obesity hypoventilation, neuromuscular and chest-wall disease. It improves symptoms, gas exchange, quality of life and, in selected groups, survival and hospital admissions.

Red flags

  • Rising CO2 or falling saturations despite NIV
  • Bulbar weakness with aspiration risk
  • Rapidly declining vital capacity in neuromuscular disease
  • Acute decompensation requiring hospital NIV/ICU

Assessment

Differential diagnosis

  • Obesity hypoventilation syndrome
  • COPD with chronic hypercapnia
  • Neuromuscular disease (e.g. motor neurone disease, muscular dystrophy)
  • Chest-wall disease (kyphoscoliosis)
  • Overlap syndrome (OSA + COPD)

Investigations

  • Arterial blood gas showing chronic daytime hypercapnia (and compensation)
  • Overnight oximetry and transcutaneous CO2 monitoring
  • Spirometry / lung volumes; sniff nasal inspiratory pressure or vital capacity in neuromuscular disease
  • Sleep study to assess coexistent OSA
  • Echocardiogram for cor pulmonale
  • Nutritional and swallow assessment in neuromuscular disease

Management

  • Confirm chronic hypercapnic respiratory failure with blood gases
  • Identify the underlying disease and reversible contributors
  • In COPD, confirm persistent hypercapnia (PaCO2 elevated) after recovery from any acute exacerbation
  • Select appropriate interface and bilevel settings aiming to lower CO2
  • Titrate inspiratory and expiratory pressures to control hypoventilation and obstructive events
  • In neuromuscular disease, initiate early based on symptoms, vital capacity decline or nocturnal hypoventilation
  • Monitor overnight gas exchange and adjust settings
  • Educate on mask use, cleaning, humidification and alarm/emergency plans
  • Arrange cough-assist and secretion management in neuromuscular disease
  • Review adherence, symptoms and blood gases regularly and link to palliative/advance-care planning where relevant

Drugs & doses

No specific drug; NIV is device therapy
Oxygen entrained into the circuit titrated to target saturation if needed
Optimise bronchodilators/diuretics for the underlying disease
Secretion management (e.g. nebulised saline, mucolytics) as adjunct

Disposition

Home ventilation service; regular physiology review; integrate with neurology/palliative care for progressive disease.

Complications & pitfalls

  • Mask-related pressure injury
  • Aspiration and secretion retention
  • Aerophagia and gastric distension
  • Failure requiring escalation / tracheostomy ventilation

Exam pearls

  • High-intensity NIV targeting CO2 reduction improves outcomes in stable hypercapnic COPD
  • Start home NIV in COPD only after persistent hypercapnia is confirmed post-exacerbation, not during the acute event
  • In neuromuscular disease, initiate before severe decompensation — monitor vital capacity trends
  • Pair NIV with mechanical insufflation-exsufflation for weak cough

Disclaimer: Educational decision support for qualified clinicians and students — not a substitute for clinical judgement, local protocols or a full drug reference. Confirm every dose and contraindication against your formulary before prescribing.